Literature DB >> 6836839

Evaluation of cytologic techniques for diagnosis of prostate cancer.

R Sharifi, M Shaw, V Ray, H Rhee, S Nagubadi, P Guinan.   

Abstract

Two hundred forty-eight male patients seen on a urology service were diagnostically screened using four different cytologic tests for cancer of the prostate. The tests included voided urine cytology, prostate massage cytology, aspiration cytology, and postmassage urine cytology. The aspiration cytology was the most efficient screening test for the diagnosis of prostate malignancy.

Entities:  

Mesh：

Year:  1983        PMID： 6836839     DOI： 10.1016/0090-4295(83)90170-x

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  8 in total

1.  Epigenetic field alterations in non-tumor prostate tissues detect prostate cancer in urine.

Authors:  Tariq A Khemees; Bing Yang; Adam Schultz; Glenn O Allen; Joseph Gawdzik; Aman Nihal; Kyle A Richards; E Jason Abel; David F Jarrard
Journal:  Am J Clin Exp Urol       Date:  2021-12-15

2.  Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid.

Authors:  Yasushi Nakai; Makito Miyake; Satoshi Anai; Shunta Hori; Yoshihiro Tatsumi; Yosuke Morizawa; Sayuri Onisi; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Lasers Med Sci       Date:  2018-05-04       Impact factor: 3.161

3.  Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology.

Authors:  Kazutoshi Fujita; Christian P Pavlovich; George J Netto; Yuko Konishi; William B Isaacs; Syed Ali; Angelo De Marzo; Alan K Meeker
Journal:  Hum Pathol       Date:  2009-04-14       Impact factor: 3.466

4.  Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.

Authors:  Douglas H Campbell; Maria E Lund; Aline L Nocon; Paul J Cozzi; Mark Frydenberg; Paul De Souza; Belinda Schiller; Jennifer L Beebe-Dimmer; Julie J Ruterbusch; Bradley J Walsh
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

5.  Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection.

Authors:  William E Jarrard; Adam Schultz; Tyler Etheridge; Shivashankar Damodaran; Glenn O Allen; David Jarrard; Bing Yang
Journal:  PLoS One       Date:  2019-06-24       Impact factor: 3.240

Review 6.  Approaches to urinary detection of prostate cancer.

Authors:  Jillian N Eskra; Daniel Rabizadeh; Christian P Pavlovich; William J Catalona; Jun Luo
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-01-17       Impact factor: 5.554

7.  Isolation of Circulating Tumor Cells from Seminal Fluid of Patients with Prostate Cancer Using Inertial Microfluidics.

Authors:  Alexey S Rzhevskiy; Alina Y Kapitannikova; Steven A Vasilescu; Tamilla A Karashaeva; Sajad Razavi Bazaz; Mark S Taratkin; Dmitry V Enikeev; Vladimir Y Lekarev; Evgeniy V Shpot; Denis V Butnaru; Sergey M Deyev; Jean Paul Thiery; Andrei V Zvyagin; Majid Ebrahimi Warkiani
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

8.  Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.

Authors:  Yasushi Nakai; Satoshi Anai; Masaomi Kuwada; Makito Miyake; Yoshitomo Chihara; Nobumichi Tanaka; Akihide Hirayama; Katsunori Yoshida; Yoshihiko Hirao; Kiyohide Fujimoto
Journal:  BMC Urol       Date:  2014-08-03       Impact factor: 2.264
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.